The Future of Innovative Medicine Pricing and Reimbursement in China: Signals from the 2024 NRDL Negotiations
These developments call for a global pricing strategy rooted in China's evolving reimbursement infrastructure, breaking siloed thinking to balance short-term goals with long-term growth.
5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment
In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
China Aims to Establish a High-Quality All-Inclusive Commercial Health Insurance System in Five Years
City Commercial Health Insurance ("Huiminbao") has been rapidly advancing, focusing on protecting the entire population against major illnesses,
Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China
Shanghai utilizes value-based pricing negotiations and performance-linked payments for medical consumable reimbursements, providing insights into the future direction of high-value medical consumable reimbursement under China's basic medical insurance.